Damon Feng Wang

Dr. Damon (Feng) Wang is a scientist entrepreneur. Currently, he's the co-founder & CEO of NuCyRNA Therapeutics, a startup aiming to redefine RNA-targeting therapeutics. NuCyRNA's initial focus is neurological disorders, such as Amyotrophic Lateral Sclerosis (ALS). Prior to this, he received extensive training both in science and business during his PhD program at Jonathan Watts lab (2018-2023) in RNA Therapeutics Institute. He specialized in engineering oligonucleotides (siRNA, ASO) and mRNA during his PhD studies, resulting in several publications in prestigious journals and a few patents.